Please note that RYDAPT®▼ (midostaurin) is not subject to additional monitoring in Northern Ireland.
Rate this content:
Welcome to the Novartis portal for UK healthcare professionals (HCPs) and other relevant decision makers*, where you can find promotional information about Novartis products, therapy area materials and professional resources.
*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.